CirrusDx, Inc. (CirrusDx), an infectious disease laboratory and diagnostics company, today announced it now offers ...

The US Food and Drug Administration (FDA) on Wednesday launched a new website aimed at improving access to information that can help healthcare professionals determine which drugs are most likely to ...

McGill researchers have developed a diagnostic system capable of identifying bacteria—and determining which antibiotics can stop them—in just 36 minutes, a major advance in the global effort to curb ...

In a multinational randomized trial, rapid antimicrobial susceptibility testing (AST) shortened the time to antibiotic modification in patients with gram-negative bacteremia but did not improve the ...

To mark World Antimicrobial Awareness Week, researchers supported by the Oxford Martin Programme on Antimicrobial Resistance Testing (University of Oxford) have reported advances towards a novel and ...

Metagenomic sequencing can provide rapid and actionable antimicrobial resistance predictions to treat bloodstream infections much faster than conventional laboratory tests, and has the potential to ...

The threat of antibiotic-resistant strains of infection is an escalating global health concern and improved targeting of antibiotics is crucial in reducing the spread of resistance. Current ...

A randomized trial involving gram-negative bacterial bloodstream infections found that rapid antibiotic susceptibility testing (AST) was not superior to usual testing in terms of clinical outcomes.

Shanx Medtech BV raised €15 million (US$17.5 million) in a seed funding round for its in vitro diagnostic platform for ultra-rapid antimicrobial susceptibility testing. The financing came from a range ...